Loading provider…
Loading provider…
Infectious Disease Physician in Baltimore, MD
NPI: 1467409359Primary Practice Location
UNIVERSITY OF MD MEDICAL CENTER MIDTOWN CAMPUS
827 Linden Ave, Baltimore, MD
Primary Employer
University of Maryland Medical Group - Infectious Disease
umaryland.edu
HQ Phone
Get M.D. David's Phone Numberphone_androidMobile
Get M.D. David's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
University of Maryland Program
fellowship • Infectious Disease
2006 - 2008
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 77 | 225 |
| 2 | 99223Initial hospital inpatient care, typically 70 minutes per day | 45 | 45 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 30 | 37 |
| 4 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 27 | 36 |
| 5 | 99213Established patient office or other outpatient visit, typically 15 minutes | 18 | 22 |
Authors: Luo, Qianlai, Horner, Marie-Josèphe, Haas, Cameron B, McGee-Avila, Jennifer K, Pfeiffer, Ruth M, Engels, Eric A, Pawlish, Karen, Monterosso, Analise, Riedel, David J, Wu, Xiao-Cheng, Gonsalves, Lou, Speers, Suzanne, Cohen, Colby, Shiels, Meredith S
Journal: Clin Infect Dis
Authors: Martin Edelman, Katherine Scilla, Josephine Feliciano
Journal: Lung Cancer
Publication Date: 2018-06-26
Lead Sponsor: University of Maryland, Baltimore
Intervention / Treatment: DRUG: Switch to Maraviroc + Raltegravir or Dolutegravir